Extended Data Fig. 7: EGLN1 and VHL are selectively essential in tRCC cells. | Nature Metabolism

Extended Data Fig. 7: EGLN1 and VHL are selectively essential in tRCC cells.

From: Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinoma

Extended Data Fig. 7

a, HIF1A mRNA level in ccRCC or tRCC tumours from three independent studies (TCGA, Motzer et al., Elias et al. (PDX))20,21,22. b, HIF1A mRNA level in tRCC cell lines (n = 3, UOK109, FU-UR-1, s-TFE) versus ccRCC cell lines (n = 7, A498, A704, 786-O, 769-P, Caki-1, Caki-2, OS-RC-2). c, OCR after knockout of VHL in UOK109 and s-TFE cell lines. Data are shown as mean -+ s.d. for n = 8 (UOK109 control sgRNA), n = 12 (UOK109 VHL sgRNA-1), n = 11 (UOK109 VHL sgRNA-2), n = 13 (s-TFE control sgRNA, s-TFE VHL sgRNA-1) and n = 10 (s-TFE VHL sgRNA-2) biological replicates. d, Genes whose knockout has been previously reported27 to confer sensitivity (422 genes) or resistance (79 genes) to NRF2 activation were compared for dependency in s-TFE cells vs. ccRCC cells (average of dependency score for 5 ccRCC cell lines, for each gene). e, Western blot showing the expression of EGLN1, VHL, HIF-1-α after knockout of VHL in ccRCC (786-O) and tRCC (UOK109, s-TFE and FU-UR-1) cell lines. f, Cell proliferation of tRCC cell lines (UOK109 and s-TFE) and ccRCC (786-O) cell lines after knockout of VHL. Data are shown as mean -+ s.d. for n = 3 (UOK109, 786-O) and n = 5 (s-TFE) biological replicates. g, Western blot showing the expression of EGLN1, VHL after knockout of EGLN1 or VHL in tRCC (FU-UR-1) cell line. h, Cell proliferation of FU-UR-1 cells after knockout of EGLN1 or VHL. Data are shown as mean -+ s.d. for n = 3 biological replicates. i, Western blot showing the expression of EGLN1, VHL after knockout of EGLN1 or VHL in ccRCC (Caki-1) cell line. j, Cell proliferation of Caki-1 cells (VHL preserved) after knockout of EGLN1 or VHL. Data are shown as mean -+ s.d. for n = 6 biological replicates. k, Western blot showing the HIF-1-α expression in UOK109 and s-TFE expressing sgRNA target HIF1A after treatment with EGLN inhibitor (FG4592). Western blot performed once. For (a) and (d), statistical significance was determined by two-sided Mann–Whitney test. Centre line, median; box limits, upper and lower quartiles; whiskers, 1.5 times the interquartile range. For (f), (h) and (j), statistical significance was determined by two-tailed Student’s t-test.

Source data

Back to article page